The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Insulin Pens Market Research Report 2025

Global Insulin Pens Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1805845

No of Pages : 88

Ask Your Query

Report Description
Table of Content

Synopsis
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.

Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.

The global Insulin Pens market was valued at US$ 4393.6 million in 2023 and is anticipated to reach US$ 7316.7 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.

EU is the largest Insulin Pen market with about 48% market share. Asia is follower, accounting for about 27% market share.
The key players are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee etc. Top 3 companies occupied about 69% market share.

This report aims to provide a comprehensive presentation of the global market for Insulin Pens, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Pens.

Report Scope

The Insulin Pens market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Pens market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin Pens manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed
Owen Mumford
HTL-Strefa
Beipu
Kangdelai
Ulticare
Allison Medical
Dongbao

Segment by Type

Standard Insulin Pen Needles
Safety Insulin Pen Needles

Segment by Application

Home Use
Medical Institutions
Others

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Netherlands)
Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Pens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Pens in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Insulin Pens Market Overview
1.1 Product Overview and Scope of Insulin Pens
1.2 Insulin Pens Segment by Type
1.2.1 Global Insulin Pens Market Value Comparison by Type (2024-2030)
1.2.2 Standard Insulin Pen Needles
1.2.3 Safety Insulin Pen Needles
1.3 Insulin Pens Segment by Application
1.3.1 Global Insulin Pens Market Value by Application: (2024-2030)
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Global Insulin Pens Market Size Estimates and Forecasts
1.4.1 Global Insulin Pens Revenue 2019-2030
1.4.2 Global Insulin Pens Sales 2019-2030
1.4.3 Global Insulin Pens Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Pens Market Competition by Manufacturers
2.1 Global Insulin Pens Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Pens Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Pens Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Pens Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Pens, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Pens, Product Type & Application
2.7 Insulin Pens Market Competitive Situation and Trends
2.7.1 Insulin Pens Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Pens Players Market Share by Revenue
2.7.3 Global Insulin Pens Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Pens Retrospective Market Scenario by Region
3.1 Global Insulin Pens Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Pens Global Insulin Pens Sales by Region: 2019-2030
3.2.1 Global Insulin Pens Sales by Region: 2019-2024
3.2.2 Global Insulin Pens Sales by Region: 2025-2030
3.3 Global Insulin Pens Global Insulin Pens Revenue by Region: 2019-2030
3.3.1 Global Insulin Pens Revenue by Region: 2019-2024
3.3.2 Global Insulin Pens Revenue by Region: 2025-2030
3.4 North America Insulin Pens Market Facts & Figures by Country
3.4.1 North America Insulin Pens Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Pens Sales by Country (2019-2030)
3.4.3 North America Insulin Pens Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Pens Market Facts & Figures by Country
3.5.1 Europe Insulin Pens Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Pens Sales by Country (2019-2030)
3.5.3 Europe Insulin Pens Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Pens Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Pens Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Pens Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Pens Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Pens Market Facts & Figures by Country
3.7.1 Latin America Insulin Pens Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Pens Sales by Country (2019-2030)
3.7.3 Latin America Insulin Pens Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Pens Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Pens Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Pens Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Pens Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Pens Sales by Type (2019-2030)
4.1.1 Global Insulin Pens Sales by Type (2019-2024)
4.1.2 Global Insulin Pens Sales by Type (2025-2030)
4.1.3 Global Insulin Pens Sales Market Share by Type (2019-2030)
4.2 Global Insulin Pens Revenue by Type (2019-2030)
4.2.1 Global Insulin Pens Revenue by Type (2019-2024)
4.2.2 Global Insulin Pens Revenue by Type (2025-2030)
4.2.3 Global Insulin Pens Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Pens Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Pens Sales by Application (2019-2030)
5.1.1 Global Insulin Pens Sales by Application (2019-2024)
5.1.2 Global Insulin Pens Sales by Application (2025-2030)
5.1.3 Global Insulin Pens Sales Market Share by Application (2019-2030)
5.2 Global Insulin Pens Revenue by Application (2019-2030)
5.2.1 Global Insulin Pens Revenue by Application (2019-2024)
5.2.2 Global Insulin Pens Revenue by Application (2025-2030)
5.2.3 Global Insulin Pens Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Pens Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BD Insulin Pens Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novo Nordisk Insulin Pens Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Artsana
6.3.1 Artsana Corporation Information
6.3.2 Artsana Description and Business Overview
6.3.3 Artsana Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Artsana Insulin Pens Product Portfolio
6.3.5 Artsana Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Corporation Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B. Braun Insulin Pens Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Corporation Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Terumo Insulin Pens Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Ypsomed
6.6.1 Ypsomed Corporation Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ypsomed Insulin Pens Product Portfolio
6.6.5 Ypsomed Recent Developments/Updates
6.7 Owen Mumford
6.6.1 Owen Mumford Corporation Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Owen Mumford Insulin Pens Product Portfolio
6.7.5 Owen Mumford Recent Developments/Updates
6.8 HTL-Strefa
6.8.1 HTL-Strefa Corporation Information
6.8.2 HTL-Strefa Description and Business Overview
6.8.3 HTL-Strefa Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.8.4 HTL-Strefa Insulin Pens Product Portfolio
6.8.5 HTL-Strefa Recent Developments/Updates
6.9 Beipu
6.9.1 Beipu Corporation Information
6.9.2 Beipu Description and Business Overview
6.9.3 Beipu Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beipu Insulin Pens Product Portfolio
6.9.5 Beipu Recent Developments/Updates
6.10 Kangdelai
6.10.1 Kangdelai Corporation Information
6.10.2 Kangdelai Description and Business Overview
6.10.3 Kangdelai Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kangdelai Insulin Pens Product Portfolio
6.10.5 Kangdelai Recent Developments/Updates
6.11 Ulticare
6.11.1 Ulticare Corporation Information
6.11.2 Ulticare Insulin Pens Description and Business Overview
6.11.3 Ulticare Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ulticare Insulin Pens Product Portfolio
6.11.5 Ulticare Recent Developments/Updates
6.12 Allison Medical
6.12.1 Allison Medical Corporation Information
6.12.2 Allison Medical Insulin Pens Description and Business Overview
6.12.3 Allison Medical Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Allison Medical Insulin Pens Product Portfolio
6.12.5 Allison Medical Recent Developments/Updates
6.13 Dongbao
6.13.1 Dongbao Corporation Information
6.13.2 Dongbao Insulin Pens Description and Business Overview
6.13.3 Dongbao Insulin Pens Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dongbao Insulin Pens Product Portfolio
6.13.5 Dongbao Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Pens Industry Chain Analysis
7.2 Insulin Pens Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Pens Production Mode & Process
7.4 Insulin Pens Sales and Marketing
7.4.1 Insulin Pens Sales Channels
7.4.2 Insulin Pens Distributors
7.5 Insulin Pens Customers
8 Insulin Pens Market Dynamics
8.1 Insulin Pens Industry Trends
8.2 Insulin Pens Market Drivers
8.3 Insulin Pens Market Challenges
8.4 Insulin Pens Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}